140 related articles for article (PubMed ID: 32411628)
1. Validation of prognostic impact of ADV score for resection of hepatocellular carcinoma: analysis using Korea Liver Cancer Registry Database.
Park GC; Hwang S; Park YH; Choi JU;
Ann Surg Treat Res; 2020 May; 98(5):235-246. PubMed ID: 32411628
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Prediction of Posttransplant Hepatocellular Carcinoma Prognosis Using ADV Score: Validation with Korea-Nationwide Transplantation Registry Database.
Park GC; Hwang S; You YK; Choi Y; Kim JM; Joo DJ; Ryu JH; Choi D; Kim BW; Kim DS; Nah YW; Kang KJ; Cho JY; Yu HC; Kim DG
J Gastrointest Surg; 2023 Jul; 27(7):1353-1366. PubMed ID: 37039979
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Accuracy of the ADV Score Following Resection of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis.
Hwang S; Moon DB; Kim KH; Ahn CS; Song GW; Jung DH; Park GC; Lee SG
J Gastrointest Surg; 2021 Jul; 25(7):1745-1759. PubMed ID: 32948961
[TBL] [Abstract][Full Text] [Related]
4. Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea-Japan collaborative study with 9200 patients.
Kang WH; Hwang S; Kaibori M; Kim JM; Kim KS; Kobayashi T; Kayashima H; Koh YS; Kubota K; Mori A; Takeda Y; Yun SS; Matsui K; Toriguchi K; Nagano H; Yoon MH; Soejima Y; Ariizumi S; Kim BS; Park Y; Yu HC; Kim BW; Lee JB; Park SJ; Jang JY; Yamaue H; Nakamura M; Yamamoto M; Endo I; ;
J Hepatobiliary Pancreat Sci; 2023 Aug; 30(8):993-1005. PubMed ID: 36808234
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Prognostic Prediction Using ADV Score for Hepatocellular Carcinoma Following Living Donor Liver Transplantation.
Hwang S; Song GW; Ahn CS; Kim KH; Moon DB; Ha TY; Jung DH; Park GC; Yoon YI; Lee SG
J Gastrointest Surg; 2021 Oct; 25(10):2503-2515. PubMed ID: 33532981
[TBL] [Abstract][Full Text] [Related]
6. Validation of the OncoHepa test, a multigene expression profile test, and the tumor marker-volume score to predict postresection outcome in small solitary hepatocellular carcinomas.
Ha SM; Hwang S; Park JY; Lee YJ; Kim KH; Song GW; Jung DH; Yu YS; Kim J; Lee KJ; Tak E; Park YH; Lee SG
Ann Surg Treat Res; 2018 Dec; 95(6):303-311. PubMed ID: 30505821
[TBL] [Abstract][Full Text] [Related]
7. Small Hepatocellular Carcinoma With Low Tumor Marker Expression Benefits More From Anatomical Resection Than Tumors With Aggressive Biology.
Jung DH; Hwang S; Lee YJ; Kim KH; Song GW; Ahn CS; Moon DB; Lee SG
Ann Surg; 2019 Mar; 269(3):511-519. PubMed ID: 28837444
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Post-resection Prognosis Using the ADV Score for Huge Hepatocellular Carcinomas ≥13 cm.
Hwang S; Kim KH; Moon DB; Ahn CS; Ha TY; Song GW; Jung DH; Park GC
J Liver Cancer; 2021 Mar; 21(1):45-57. PubMed ID: 37384269
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of serum soluble PD-1 and ADV score for living donor liver transplantation in patients with previously untreated hepatocellular carcinoma.
Hwang S; Lee KJ; Moon DB; Song GW; Jung DH; Kim YK; Yang H; An DE; Lee S; Lee SG
Ann Surg Treat Res; 2022 Jan; 102(1):46-54. PubMed ID: 35071119
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Prediction Models for Resection of Large Hepatocellular Carcinoma: A Korean Multicenter Study.
Hwang S; Joh JW; Wang HJ; Kim DG; Kim KS; Suh KS; Kim SH; Yu HC; Cho CK; Lee YJ; Kim KH; Kim JM; Kim BW; Lee SG
World J Surg; 2018 Aug; 42(8):2579-2591. PubMed ID: 29340726
[TBL] [Abstract][Full Text] [Related]
11. Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma.
Chon YE; Choi GH; Lee MH; Kim SU; Kim DY; Ahn SH; Kim KS; Choi JS; Han KH; Chon CY; Park JY
Int J Cancer; 2012 Nov; 131(10):2332-41. PubMed ID: 22362471
[TBL] [Abstract][Full Text] [Related]
12. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
13. The ratio of serum des-gamma-carboxy prothrombin to tumor volume as a new biomarker for early recurrence of resected hepatocellular carcinoma.
Shimagaki T; Yoshizumi T; Itoh S; Iseda N; Tomiyama T; Morinaga A; Wang H; Kurihara T; Nagao Y; Toshima T; Harada N; Kinjo N; Maeda T; Mori M
Hepatol Res; 2022 Apr; 52(4):381-389. PubMed ID: 35089647
[TBL] [Abstract][Full Text] [Related]
14. Outcomes following liver resection for multinodular Barcelona Clinic Liver Cancer-B hepatocellular carcinoma.
Matsukuma S; Sakamoto K; Tokuhisa Y; Tokumitsu Y; Matsui H; Kanekiyo S; Tomochika S; Iida M; Suzuki N; Takeda S; Ueno T; Wada H; Kobayashi S; Saeki I; Eguchi H; Sakon M; Sakaida I; Nagano H
Oncol Lett; 2018 Nov; 16(5):6383-6392. PubMed ID: 30344760
[TBL] [Abstract][Full Text] [Related]
15. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S; Rhim H; Kim YS; Kang TW; Song KD
Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
[TBL] [Abstract][Full Text] [Related]
16. The Half-Life of Serum Des-Gamma-Carboxy Prothrombin Is a Prognostic Index of Survival and Recurrence After Liver Resection for Hepatocellular Carcinoma.
Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):921-928. PubMed ID: 27638677
[TBL] [Abstract][Full Text] [Related]
17. [Study on the value of serum des-γ-carboxy prothrombin in predicting hepatocellular carcinoma recurrence after liver transplantation].
Xu Y; Wang PX; Cheng JW; Huang XW; Zhou J; Fan J; Yang XR
Zhonghua Gan Zang Bing Za Zhi; 2020 Nov; 28(11):918-923. PubMed ID: 33256276
[No Abstract] [Full Text] [Related]
18. Chronic schistosomiasis japonica is an independent adverse prognostic factor for survival in hepatocellular carcinoma patients who have undergone hepatic resection: clinicopathological and prognostic analysis of 198 consecutive patients.
Matsuda M; Fujii H
World J Surg; 2009 Dec; 33(12):2644-50. PubMed ID: 19771467
[TBL] [Abstract][Full Text] [Related]
19. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection.
Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Chen LP
Medicine (Baltimore); 2018 Jul; 97(29):e11599. PubMed ID: 30024565
[TBL] [Abstract][Full Text] [Related]
20. The tumor marker score is an independent predictor of survival in patients with recurrent hepatocellular carcinoma.
Okamura Y; Ashida R; Ito T; Sugiura T; Mori K; Uesaka K
Surg Today; 2015 Dec; 45(12):1513-20. PubMed ID: 25527455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
